Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ornithine phenylacetate

EU orphan designation number: EU/3/11/945   
Active ingredient: Ornithine phenylacetate
Indication: Treatment of acute liver failure
Sponsor: Voisin Consulting S.A.R.L.
3 rue des Longs Prés, F-92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/01/2012 Centralised Orphan - Designation EMA/OD/105/11 (2012)131 of 11/01/2012
26/09/2014 Centralised Orphan - Transfer of orphan designation EMA/OD/105/11/T/01 (2014)7017 of 24/09/2014